Trial Profile
A Phase 1, Randomized, Single Dose, Placebo And Active Controlled, 3-Way Crossover Study To Evaluate The Effect Of A Single Oral Dose Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Mar 2012
Price :
$35
*
At a glance
- Drugs Lersivirine (Primary) ; Moxifloxacin
- Indications Bacterial infections; HIV infections
- Focus Adverse reactions
- 27 Feb 2012 Results published in Antimicrobial Agents and Chemotherapy.
- 03 Sep 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 03 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.